One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1182/blood.v118.21.3711.3711
Copy DOI Journal: Blood |  Publication Date: Nov 18, 2011 |
 Citations: 9 |
Affiliation: University of Alabama at Birmingham, Baylor University Medical Center, Stanford Medicine, Washington University in St. Louis, City Of Hope National Medical Center, The University of Texas MD Anderson Cancer Center, Fred Hutch Cancer Center, New York University Langone Medical Center, Nationwide Children's Hospital, Loyola University Chicago, Seagen (United States), Colorado Blood Cancer InstituteProlonged Treatment with Brentuximab Vedotin (SGN-35) in Patients with Relapsed or Refractory Hodgkin Lymphoma (HL) or Systemic Anaplastic Large Cell Lymphoma (sALCL),
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
